CANNAINVESTOR Magazine February / March 2017 - Page 71

He is also a board member of Israel-based CannRX, a company focused on the development of cannabis-based pharmaceuticals in Israel; and Kanna Enterprises, a product development, marketing and distribution company whose primary product is CanaGel a unique hemp/CBD oral delivery gel which utilizes a patented delivery system.

Jeffrey Friedland is also the CEO of the financial services firm Friedland Global Capital. Since 1979 the firm has provided corporate finance and strategic advisory services to entrepreneurial companies in emerging markets and assists companies with non-US stock market listings with the establishment of depositary receipt (DR) programs in the United States. The firm has been active in countries including China, Hong Kong, Sri Lanka, Indonesia and Brazil.

Mr. Friedland has been the chief executive officer and a director of a NASDAQ listed financial services company, a director and chairman of the audit committee of a New York Stock Exchange listed company, and chairman of a company listed on the EU-regulated market of the Frankfurt Stock Exchange.

He is an author, speaker and thought leader on emerging markets, the global economy and the cannabis industry.

Mr. Friedland has been featured or quoted in numerous publications including the Wall Street Journal, Reuters, the New York Times, Bloomberg Television, USA Today, Verslo Zinios (Lithuania), Vercernji (Croatia), International Business Times , the South China Morning Post, the Guam Daily Post, the Forward, the Jewish Week , Quartz , the Jakarta Globe, Israel Daily Television, BreitBart, NBC.com and Forbes

139

97

CANNA

INVESTOR

Webcast

45-minute live presentations and Q&A by CEOs, CFOs, and IROs of publicly-traded and privately-held cannabis companies. Visit cannawebcast.com

to register for live presentations!

Monthly Webcast

For replay visit our YOUTUBE Channel!

71